289
Views
12
CrossRef citations to date
0
Altmetric
Original Research

GOLD Classifications, COPD Hospitalization, and All-Cause Mortality in Chronic Obstructive Pulmonary Disease: The HUNT Study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & show all
Pages 225-233 | Published online: 31 Jan 2020

References

  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diesease. 2017 Available from: http://goldcopd.org/. Accessed 018 2017.
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diesease. 2011 Available from: http://goldcopd.org/. Accessed 018 2016.
  • VestboJ, HurdSS, Rodriguez-RoisinR. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) – why and what? Clin Respir J. 2012;6(4):208–214. doi:10.1111/crj.1200222906068
  • SorianoJB, LamprechtB, RamirezAS, et al. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. Lancet Respir Med. 2015;3(6):443–450. doi:10.1016/S2213-2600(15)00157-525995071
  • JohannessenA, NilsenRM, StoreboM, GulsvikA, EaganT, BakkeP. Comparison of 2011 and 2007 global initiative for chronic obstructive lung disease guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med. 2013;188(1):51–59. doi:10.1164/rccm.201212-2276OC23590268
  • LangeP, MarottJL, VestboJ, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186(10):975–981. doi:10.1164/rccm.201207-1299OC22997207
  • ChenCZ, OuCY, HsuCH, HsiueTR. Validation of the GOLD 2013 classification in predicting exacerbations and mortality in Taiwanese patients with chronic obstructive pulmonary disease. J Formosan Med Assoc. 2015;114(12):1258–1266. doi:10.1016/j.jfma.2014.12.00325676673
  • LeivsethL, BrumptonBM, NilsenTIL, MaiX-M, JohnsenR, LanghammerA. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway. Thorax. 2013;68(10):914. doi:10.1136/thoraxjnl-2013-20327023611880
  • GedebjergA, SzepligetiSK, WackerhausenLH, et al. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new global initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study. Lancet Respir Med. 2018;6(3):204–212. doi:10.1016/S2213-2600(18)30002-X29331311
  • Cabrera LopezC, Casanova MacarioC, Marin TrigoJM, et al. Comparison of the 2017 and 2015 global initiative for Chronic Obstructive Lung Disease reports. Impact on grouping and outcomes. Am J Respir Crit Care Med. 2018;197(4):463–469. doi:10.1164/rccm.201707-1363OC29099607
  • CrinerRN, LabakiWW, ReganEA; for the COPD Gene Investigators, et al. Mortality and exacerbations by global initiative for Chronic Obstructive Lung Disease Groups ABCD: 2011 versus 2017 in the COPDGene® Cohort. Chronic Obstr Pulm Dis. 2019;6(1):64–73. doi:10.15326/jcopdf.6.1.2018.0130.30775425
  • HanM-Z, HsiueT-R, TsaiS-H, HuangT-H, LiaoX-M, ChenC-Z. Validation of the GOLD 2017 and new 16 subgroups (1A-4D) classifications in predicting exacerbation and mortality in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:3425–3433. doi:10.2147/COPD.S17904830425472
  • KrokstadS, LanghammerA, HveemK, et al. Cohort profile: the HUNT study, Norway. Int J Epidemiol. 2013;42(4):968–977. doi:10.1093/ije/dys09522879362
  • BhattaL, LeivsethL, MaiX-M, et al. Prevalence and trend of COPD from 1995–1997 to 2006–2008: the HUNT study, Norway. Respir Med. 2018;138:50–56. doi:10.1016/j.rmed.2018.03.02029724393
  • QuanjerPH, TammelingGJ, CotesJE, PedersenOF, PeslinR, YernaultJC. Lung volumes and forced ventilatory flows. report working party standardization of lung function tests, european community for steel and coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5–40. doi:10.1183/09041950.005s16938499054
  • LanghammerA, JohannessenA, HolmenTL, et al. Global lung function initiative 2012 reference equations for spirometry in the Norwegian population. Eur Respir J. 2016;48(6):1602–1611. doi:10.1183/13993003.00443-201627824594
  • Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107–1136. doi:10.1164/ajrccm.152.3.76637927663792
  • HankinsonJL, EschenbacherB, TownsendM, StocksJ, QuanjerPH. Use of forced vital capacity and forced expiratory volume in 1 second quality criteria for determining a valid test. Eur Respir J. 2015;45(5):1283–1292. doi:10.1183/09031936.0011681425537554
  • QuanjerPH, StanojevicS, ColeTJ, et al. Multi-ethnic reference values for spirometry for the 3–95 year age range: the global lung function 2012 equations: report of the Global Lung Function Initiative (GLI), ERS Task Force to establish improved lung function reference values. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.0008031222743675
  • MahlerDA, WellsCK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580–586. doi:10.1378/chest.93.3.5803342669
  • BroggerJC, BakkePS, GulsvikA. Comparison of respiratory symptoms questionnaires. Int J Tubercul Lung Dis. 2000;4(1):83–90.
  • HolmenJ, MidthjellK, KrügerØ, et al. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiol. 2003;13(1):19–32.
  • Northern Norway Regional Health Authority: Centre for Clinical Documentation and Evaluation (SKDE). COPD healthcare atlas. 2018 Available from: https://helseatlas.no/sites/default/files/copd-healthcare-atlas.pdf. Accessed 103 2019.
  • GrambschPM, TherneauTM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515–526. doi:10.1093/biomet/81.3.515
  • BelsleyDA, KuhE, WelschRE. Regression Diagnostics: Identifying Influential Data and Sources of Collinearity. New York (N.Y.): Wiley; 1980.
  • O’BrienRM. A caution regarding rules of thumb for variance inflation factors. Qual Quant. 2007;41(5):673–690. doi:10.1007/s11135-006-9018-6
  • BozdoganH. Model selection and Akaike’s Information Criterion (AIC): the general theory and its analytical extensions. Psychometrika. 1987;52(3):345–370. doi:10.1007/BF2294361
  • KamarudinAN, CoxT, Kolamunnage-DonaR. Time-dependent ROC curve analysis in medical research: current methods and applications. BMC Med Res Methodol. 2017;17(1):53. doi:10.1186/s12874-017-0332-628388943
  • HeagertyPJ, ZhengY. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61(1):92–105. doi:10.1111/biom.2005.61.issue-115737082
  • SahaP, HeagertyPJ. Time-dependent predictive accuracy in the presence of competing risks. Biometrics. 2010;66(4):999–1011. doi:10.1111/j.1541-0420.2009.01375.x20070296
  • MillerMR, PedersenOF. New concepts for expressing forced expiratory volume in 1 s arising from survival analysis. Eur Respir J. 2010;35(4):873–882. doi:10.1183/09031936.0002580919741033
  • BansalA, HeagertyPJ. A tutorial on evaluating the time-varying discrimination accuracy of survival models used in dynamic decision making. Med Decis Making. 2018;38(8):904–916. doi:10.1177/0272989X1880131230319014
  • Martínez-CamblorP, CorralN. A general bootstrap algorithm for hypothesis testing. J Stat Plan Inference. 2012;142(2):589–600. doi:10.1016/j.jspi.2011.09.003
  • MenezesAM, WehrmeisterFC, Perez-PadillaR, et al. The PLATINO study: description of the distribution, stability, and mortality according to the global initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017. Int J Chron Obstruct Pulmon Dis. 2017;12:1491–1501. doi:10.2147/COPD28553101
  • MarcoaR, RodriguesDM, DiasM, et al. Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: comparison with GOLD 2011. Copd. 2018;15(1):21–26. doi:10.1080/15412555.2017.139428529161163
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diesease. 2019 Available from: http://goldcopd.org/. Accessed 022 2019.
  • MandrekarJN. Receiver operating characteristic curve in diagnostic test assessment. J Thor Oncol. 2010;5(9):1315–1316. doi:10.1097/JTO.0b013e3181ec173d